Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 14.0 | 82 | |
RA2159 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 15.5 | 46 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 15.0 | 67 | |
N2645 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 13.5 | 48 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 11.0 | 53 | |
RA2708 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 18.0 | 63 | |
RA2159 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 16.0 | 69 | |
RA2159 | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 18.0 | 49 | ||||
N2645 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 13.0 | 38 | |
N2645 | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 15.0 | 49 | ||||
RA2708 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 17.0 | 71 | |
RA2708 | Poly(I:C) | 2 | ug/mL | 2 | IL-13 | 24.0 | 53 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-13 | 15.0 | 66 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | IL-13 | 15.0 | 53 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-13 | 14.5 | 56 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | IL-13 | 13.0 | 46 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | IL-13 | 14.0 | 53 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | IL-13 | 17.5 | 70 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | IL-13 | 16.0 | 60 | ||||
RA2159 | 2 | IL-13 | 16.0 | 55 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | IL-13 | 15.0 | 35 | ||||
N2645 | 2 | IL-13 | 12.0 | 28 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | IL-13 | 13.0 | 27 | ||||
RA2708 | 2 | IL-13 | 17.5 | 22 | |||||||
0 | IL-13 | 12.0 | 34 |